Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.

Biotechnology

Vast Therapeutics

Nate Stasko

Stan Hollenbach

Rebecca Anthouard McDonald, PhD

Mark Schoenfisch

John Simons

The Scientific Advisors and Specialists team at Vast Therapeutics provides expert guidance on research strategies, evaluates scientific data, and advises on the development of innovative therapies to combat drug-resistant microbial infections. They collaborate closely with the Director of Bacteriology and the Principal R&D Scientist to ensure the scientific integrity and efficacy of preclinical projects aimed at addressing global health threats.

Scientific Advisors and Specialists

About

Team members

Other teams at Vast Therapeutics

Leadership Team